Biosynex has raised nearly 3.8 million euros


(AOF) – Biosynex has announced the end of the exercise period of its Redeemable Share Warrants (BSARs) allocated on June 23, 2020. At the end of the exercise period of the BSARs on December 24, 2021, 8,685,927 BSARs were exercised by their holders out of the 9,135,448 issued in June 2020, resulting in the creation of 377,649 new shares at a price of 10 euros. The exercise of the BSARs was 95% completed. The total dilution generated was 3.39% for a total of 3,776,490 euros raised.

This fundraising will help accelerate the Company’s growth, in particular through external growth operations.

To date, the share capital of Biosynex now consists of 11,135,342 shares, ie a share capital of 1,113,534.20 euros.

© AOF

The AOF information reproduced on Capital.fr is taken from the AOF information service. This information is protected by intellectual property rights owned by OPTION FINANCE SAS, publisher of the AOF real-time stock market information service, and its contributors. Consequently, any reproduction, copy, duplication, modification, transfer, redistribution, translation, commercial or non-commercial exploitation, creation of hypertext link or reuse in any way whatsoever of this information is subject to the prior written agreement of OPTION FINANCE SAS and its contributors. AOF can be reached at the following address [email protected] OPTION FINANCE SAS collects its data from sources it considers the most reliable. However, subject to gross negligence, OPTION FINANCES SAS and its contributors in no way guarantee the absence of errors and defects, even hidden, nor the exhaustive nature or lack of conformity for any use whatsoever of these data and of OPTION FINANCE. SAS or one of its contributors, and cannot be held responsible for delays or interruptions that could affect access to them. The user of the OPTION FINANCE SAS service will use AOF data at his own risk and must hold OPTION FINANCE SAS and its contributors harmless from any claim resulting from this use.





Source link -92